Use of psychotropic medications in the specialist health service for mental health care and substance use disorders in 2012-23.

IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL

Tidsskrift for Den Norske Laegeforening Pub Date : 2025-05-12 Print Date: 2025-05-13 DOI:10.4045/tidsskr.24.0531

Liv Marit Seljeflot, Hege Salvesen Blix, Yvonne Andersson, Torfinn Hynnekleiv

{"title":"Use of psychotropic medications in the specialist health service for mental health care and substance use disorders in 2012-23.","authors":"Liv Marit Seljeflot, Hege Salvesen Blix, Yvonne Andersson, Torfinn Hynnekleiv","doi":"10.4045/tidsskr.24.0531","DOIUrl":null,"url":null,"abstract":"Background: Data on the use of psychotropic medications in specialist mental health services and interdisciplinary specialised treatment for substance use disorders (SUDs) are useful both as cross-sectional indicators and as time series data for monitoring trends. The figures can help form a basis for evaluating rational use of medications in hospitals.Material and method: Purchasing data for anxiolytics, antidepressants, mood stabilisers and antipsychotics from the Hospital Pharmacies Drug Statistics for the period 2012-23 were used. The data are sourced from sales to specialist mental health clinics and for SUD treatment. Defined daily doses and the number of defined daily doses per 100 bed-days were used as units of measurement.Results: Use of anxiolytics increased by 127 % from 2012 to 2023, while decreasing by 24 % for antidepressants. The use of mood stabilisers and lithium decreased by 26 % and 16 %, respectively. Total use of antipsychotics increased by 29 %, while rising by 79 % for depot injections.Interpretation: Significant changes in medication use were observed during the reference period. Further studies are needed to identify the causes and effects of the changed prescribing patterns.","PeriodicalId":23123,"journal":{"name":"Tidsskrift for Den Norske Laegeforening","volume":"145 6","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tidsskrift for Den Norske Laegeforening","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4045/tidsskr.24.0531","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/13 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Data on the use of psychotropic medications in specialist mental health services and interdisciplinary specialised treatment for substance use disorders (SUDs) are useful both as cross-sectional indicators and as time series data for monitoring trends. The figures can help form a basis for evaluating rational use of medications in hospitals.

Material and method: Purchasing data for anxiolytics, antidepressants, mood stabilisers and antipsychotics from the Hospital Pharmacies Drug Statistics for the period 2012-23 were used. The data are sourced from sales to specialist mental health clinics and for SUD treatment. Defined daily doses and the number of defined daily doses per 100 bed-days were used as units of measurement.

Results: Use of anxiolytics increased by 127 % from 2012 to 2023, while decreasing by 24 % for antidepressants. The use of mood stabilisers and lithium decreased by 26 % and 16 %, respectively. Total use of antipsychotics increased by 29 %, while rising by 79 % for depot injections.

Interpretation: Significant changes in medication use were observed during the reference period. Further studies are needed to identify the causes and effects of the changed prescribing patterns.

查看原文本刊更多论文

2012-23年精神卫生保健和物质使用障碍专科保健服务中精神药物的使用情况。

背景：在专门的精神卫生服务和药物使用障碍的跨学科专门治疗中使用精神药物的数据，无论是作为横截面指标还是作为监测趋势的时间序列数据，都是有用的。这些数字有助于形成评估医院合理使用药物的基础。材料和方法：采用2012-23年医院药房药品统计中抗焦虑药、抗抑郁药、情绪稳定药和抗精神病药的采购数据。这些数据来自销售给专业心理健康诊所和SUD治疗的数据。确定的每日剂量和每100个住院日确定的每日剂量作为计量单位。结果：从2012年到2023年，抗焦虑药的使用增加了127%，而抗抑郁药的使用减少了24%。情绪稳定剂和锂的使用分别减少了26%和16%。抗精神病药物的总使用量增加了29%，而仓库注射增加了79%。解释：在参考期内观察到药物使用的显著变化。需要进一步的研究来确定改变的处方模式的原因和影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊